Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway

E-ISSN： 1873-4294|16|13|1441-1451

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.13, 2016-05, pp. : 1441-1451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus

By Chong Benjamin F Mohan Chandra

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1147-1153

Informa Healthcare

Access to resources Recommend Favorite

CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3903-3920

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors

Current Medicinal Chemistry, Vol. 17, Iss. 27, 2010-09 ,pp. : 3019-3029

Bentham Science Publishers

Access to resources Recommend Favorite

Fragment-Based Optimization of Small Molecule CXCL12 Inhibitors for Antagonizing the CXCL12/CXCR4 Interaction

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 24, 2012-12 ,pp. : 2727-2740

Bentham Science Publishers

Access to resources Recommend Favorite

Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer

By Ma Lixin

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 508-517

Springer Publishing Company

Access to resources Recommend Favorite